Theriva Biologics Inc (TOVX): Type B multi disiplinary meeting, the wa...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Theriva Biologics Inc (TOVX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	236
Boards Moderated	0
Alias Born	09/24/2013

Re: dds2th post# 7512

Thursday, 08/03/2017 3:27:18 PM

Thursday, August 03, 2017 3:27:18 PM

Type B multi disiplinary meeting, the way I understand it, is a meeting with the various depts. of the FDA to determine what is required to bring Ribaximase to market. A phase 3 study may or may not be required.

I think that SYN stated that they plan on a phase 3 study for Ribaximase in the first half of 2018. How many patients would be involved would be up to the FDA.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TOVX News

Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:15:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:10:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:05:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 10:06:35 AM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/16/2023 09:24:26 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:53:41 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/14/2023 09:11:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:30:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 01:03:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 01:22:02 PM
Another Biotech Stealing The Premarket Spotlight • AllPennyStocks.com • 06/28/2023 02:15:00 PM

More TOVX News

InvestorsHub NewsWire

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow